Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial-Reference-Cited by-同舟云学术

Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial

Published:2013-11 Issue:16 Volume:49 Page:3431-3441
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Trovik Jone,Wik Elisabeth,Werner Henrica M.J.,Krakstad Camilla,Helland Harald,Vandenput Ingrid,Njolstad Tormund S.,Stefansson Ingunn M.,Marcickiewicz Janusz,Tingulstad Solveig,Staff Anne C.,Amant Frederic,Akslen Lars A.,Salvesen Helga B.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. Relationship between surgical–pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study;Morrow;Gynecol Oncol,1991

2. Endometrial adenocarcinoma in Norway. A study of a total population;Abeler;Cancer,1991

3. Cancer in Norway 2008 report;Bray,2009

4. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;EBCTCG EBCTCG;Lancet,2005

5. Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer;Chang;Cancer,2010

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genes Co-Expressed with ESR2 Influence Clinical Outcomes in Cancer Patients: TCGA Data Analysis;International Journal of Molecular Sciences;2024-08-09

2. PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms;Cell Reports;2024-08

3. Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma;Cancers;2024-05-30

4. Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous Components;American Journal of Surgical Pathology;2024-05-23

5. EPPK1 as a Prognostic Biomarker in Type I Endometrial Cancer and Its Correlation with Immune Infiltration;International Journal of General Medicine;2024-04